These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11147600)

  • 1. Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas.
    Kitange G; Tsunoda K; Anda T; Nakamura S; Yasunaga A; Naito S; Shibata S
    Cancer; 2000 Dec; 89(11):2292-300. PubMed ID: 11147600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas.
    Okuducu AF; Zils U; Michaelis SA; Michaelides S; von Deimling A
    Histopathology; 2006 Jun; 48(7):836-45. PubMed ID: 16722933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ETS-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma.
    Takanami I; Takeuchi K; Karuke M
    Tumour Biol; 2001; 22(4):205-10. PubMed ID: 11399944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
    Okuducu AF; Zils U; Michaelis SA; Mawrin C; von Deimling A
    Cancer; 2006 Sep; 107(6):1365-72. PubMed ID: 16894529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation.
    Grevin D; Chen JH; Raes MB; Stehelin D; Vandenbunder B; Desbiens X
    Int J Dev Biol; 1993 Dec; 37(4):519-29. PubMed ID: 8179996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
    Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
    Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
    Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
    Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
    Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
    Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
    Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
    Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.
    Utsuki S; Oka H; Sato Y; Kawano N; Tsuchiya B; Kobayashi I; Fujii K
    Clin Neuropathol; 2005; 24(1):8-12. PubMed ID: 15696778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
    Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Correlation Between Immunohistochemical Expression of SPARC and Invasion in Different Grades of Meningiomas.
    Rooprai HK; Martin AJ; King A; Appadu UD; Gullan RW; Thomas NWM; Pilkington GJ
    Anticancer Res; 2020 Jun; 40(6):3081-3089. PubMed ID: 32487602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas.
    von Randow AJ; Schindler S; Tews DS
    Pathol Res Pract; 2006; 202(5):365-72. PubMed ID: 16563650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors.
    Nakada M; Yamashita J; Okada Y; Sato H
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):329-34. PubMed ID: 10218628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signals of apoptotic pathways in several types of meningioma.
    Sabbatini M; Comi C; Chiocchetti A; Piffanelli V; Car PG; Dianzani U; Monaco F; Cannas M
    Pathol Oncol Res; 2011 Mar; 17(1):51-9. PubMed ID: 20524098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R; Torà M; Díaz VM; Real FX
    Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of MRP5 expression in meningiomas.
    Alexiou GA; Goussia A; Ntoulia A; Zagorianakou P; Malamou-Mitsi V; Voulgaris S; Kyritsis AP
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):825-8. PubMed ID: 23271324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.